» Articles » PMID: 30510359

Validation of Clinical Significance of Examined Lymph Node Count for Accurate Prognostic Evaluation of Gastric Cancer for the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System

Overview
Specialty Oncology
Date 2018 Dec 5
PMID 30510359
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To validate the necessity of increasing the examined lymph node (ELN) count for enhancing the accuracy of prognostic evaluation of gastric cancer (GC) patients after curative gastrectomy in multiple medical centers of China.

Methods: The clinicopathological data of 7,620 patients who underwent the curative resection for GC between 2001 and 2011 were included to demonstrate whether the ELN count is indispensable for enhancing the accuracy of prognostic evaluation of GC patients after surgery. After a meticulous stratification by using the cut-point survival analysis, all included 7,620 patients were allocated into three groups as: less than 16 (<16), between 16 and 30 (16-30), and more than 30 (>30) ELNs. Survival differences among various subgroups of GC patients were analyzed to assess the impact of the ELN count on the stage migration in accordance with the overall survival (OS) of GC patients.

Results: Survival analyses revealed that the ELN count was positively correlated with the OS (P=0.001) and was an independent prognostic predictor (P<0.01) of 7,620 GC patients. Stratum analysis showed that the accuracy of prognostic evaluation could be enhanced when the ELN count was no less than 16 (≥16) for node-negative patients and >30 for node-positive patients. Stage migrations were mainly detected in the various subgroups of patients with specific pN stages as follows: pN0 with 16-30 ELNs (pN0) and pN0 with >30 ELNs (pN0 ), pN0 with <16 ELNs (pN0 ) and pN1, pN1 and pN2, pN1 and pN2, pN3a and pN3b, and pN3a and pN3b. These findings indicate that increasing the ELN count is a prerequisite to guarantee precisely prognostic evaluation of GC patients.

Conclusions: The ELN count should be proposed to be >30 for acquiring the accurate prognostic evaluation for GC patients, especially for node-positive patients.

Citing Articles

Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review.

Wu Y, Shang J, Zhang X, Li N J Nanobiotechnology. 2024; 22(1):783.

PMID: 39702277 PMC: 11657939. DOI: 10.1186/s12951-024-02940-4.


Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis.

Li Y, Wu G, Liu J, Zhang Y, Yang W, Wang X BMC Cancer. 2023; 23(1):523.

PMID: 37291493 PMC: 10251690. DOI: 10.1186/s12885-023-10805-6.


Prognostic factors and the necessity of chemotherapy for stage II gastric cancer: a model based on multicenter retrospective study.

Fang J, Zhang F, Lu J, Deng Z, Li X, Chen X Discov Oncol. 2023; 14(1):58.

PMID: 37154867 PMC: 10167061. DOI: 10.1007/s12672-023-00663-w.


Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.

Nie D, Zheng H, An G, Li J J Cancer Res Clin Oncol. 2023; 149(11):8593-8603.

PMID: 37097391 DOI: 10.1007/s00432-023-04796-x.


Examined lymph node count for gastric cancer patients after curative surgery.

Zeng Y, Chen L, Ye Z, Deng J World J Clin Cases. 2023; 11(9):1930-1938.

PMID: 36998963 PMC: 10044965. DOI: 10.12998/wjcc.v11.i9.1930.


References
1.
Toth D, Biro A, Varga Z, Torok M, Arkosy P . Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary. Chin J Cancer Res. 2017; 29(4):323-332. PMC: 5592820. DOI: 10.21147/j.issn.1000-9604.2017.04.05. View

2.
Jiao X, Deng J, Zhang R, Wu L, Wang L, Liu H . Prognostic value of number of examined lymph nodes in patients with node-negative gastric cancer. World J Gastroenterol. 2014; 20(13):3640-8. PMC: 3974533. DOI: 10.3748/wjg.v20.i13.3640. View

3.
Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X . Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol. 2008; 22(10):835-9. PMC: 2661304. DOI: 10.1155/2008/761821. View

4.
Jeong J, Kim M, Ha T, Kwon S . Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer. 2013; 12(4):210-6. PMC: 3543970. DOI: 10.5230/jgc.2012.12.4.210. View

5.
Jaehne J, Meyer H, Maschek H, Geerlings H, Burns E, Pichlmayr R . Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg. 1992; 127(3):290-4. DOI: 10.1001/archsurg.1992.01420030052010. View